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a b s t r a c t
The roleofmesenchymal stromal cells (MSCs) in regulating immuneresponses in the thymus is currently
unclear. Here we report the existence and role of a MSC population in the thymus that expresses the
pericyte and MSC marker CD248 (endosialin). We show using a CD248-deﬁcient mouse model, that
CD248 expression on these cells is required for full post-natal thymus development and regeneration
post-Salmonella infection. In CD248−/− mice the thymus is hypocellular and regeneration is poorer,
with signiﬁcant loss of all thymocyte populations. This identiﬁes the requirement of CD248 tomaintain
optimal thymic cellularity post-partum and infection.
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The thymus is a specialised microenvironment for the generation
and selection of self-tolerant T-cells. Several studies have shown
that mesenchymal-derived stromal cells (MSCs) play multiple roles
in thymus development and function. While MSCs provide essential
signals directly to the developing T-cell precursors [1], evidence
suggests that MSCs can also inﬂuence thymic epithelial cell (TEC)
populations. During embryonic thymus development, interactions
between MSCs and TEC progenitors are required for the expansion
of epithelial microenvironments, providing a ﬁnite number of niches
that directly controls the efﬁcacy of intrathymic T-cell production [2].
Without MSC support, an ineffective TEC network forms, naı¨ve T-cell
maturation is severely reduced andwith it peripheral immunity [3,4].
While MSCs, including those of neural crest origin, clearly reside in
the adult thymus, their function remains poorly characterised [5,6].
As well as dynamic changes in thymus volume during development,
adult thymus commonly involutes during injurious threats such
as infection, regenerating during resolution [7]. Therefore, under-
standing the biology of thymic MSCs and their role in the post-natal
thymus is likely to help our understanding of thymic homeostasis
and regeneration following involution.
CD248 (endosialin) is a member of a family of proteins involved in* Corresponding author at: MRC Centre for Immune Regulation, University of Birm-
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to cells of mesenchymal origin [10]. In humans, CD248 is expressed
on bone marrow MSCs [11], interstitial ﬁbroblasts and perivascular
cells [12-14] a niche where MSCs have been suggested to reside after
birth [15]. We have demonstrated that murine CD248 is spatially
and temporally expressed in lymph nodes where it regulates tissue
expansion following immunisation [16]. In addition, high CD248
expression is observed during lymphoid tissue development. Ex-
pression decreases post-natally, but re-expression occurs during
inﬂammation in adult tissue [17].
Given the requirement for MSCs in the formation of embryonic
thymic microenvironments through their impact on TEC progenitors,
and the dynamic expression pattern of CD248 on MSCs during de-
velopment, we explored the possible role of CD248-expressing MSCs
in adult thymic regeneration following involution. Here we show
that CD248 is expressed on cells of the thymic capsule, and pericytes
within the thymus. In addition, using the CD248−/− mouse model
we show that CD248 expression is required for optimal post-natal
thymic growth and regeneration following infection-dependent
thymic atrophy.2.1. Mice, histology and confocal microscopy
Wild-type (WT) C57Bl/6micewere obtained fromHarlan UK Lim-
ited, Oxford, UK. eYFP C57Bl/6 mice from BMSU, Birmingham Uni-
ochemical Societies. Open access under CC BY-NC-ND license.
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versity, UK. Generation of 129Sv CD248−/− mice has been previously
described [18]. 129Sv CD248−/− mice were backcrossed onto C57Bl/
6 mice >5 generations in-house generating CD248−/− mice used
throughout. Frozen tissue sections were prepared, stained by indi-
rect immunohistochemistry and analysed by confocal microscopy as
described previously [16,17]. All experiments were performed in ac-
cordance with UK laws with approval of Local Ethics Committees.Fig. 1. Location of thymic CD248 expressing cells. Frozen sections of E12, 14 and 16
thymuseswere co-stainedwithCD248 (green) andeither PDGFRα (A) or CD31 (B) (red).
Bar = 100 μm. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)2.2. Tissue digestion and ﬂow cytometry
Thymuses were enzymatically digested as previously described
[19]. Mature thymocytes were deﬁned as CD45+CD4+CD8+ – dou-
ble positive (DP) – CD45+CD4+CD8− – CD4+ single positive (SP) –
CD45+CD4−CD8+ – CD8+ SP – or CD45+CD4−CD8− – double negative
(DN). DN subpopulations were deﬁned as previously described [20].
2.3. Salmonella infections
Attenuated Salmonella enterica serovar Typhimurium SL3261 (5
× 105) were used to immunize adult (9- to 10-week-old) WT or
CD248−/− mice via I.P. injection as previously described [21].
2.4. Determination of vessel length
Complete thymic lobes were stained with antibodies to CD31 and
whole tissue analysed using a Leica DM6000. Four nonoverlapping
areas of 1 × 1.7mmwere chosen at random and using AF6000 Image
Processing software, vessel length was measured. Data were tabu-
lated and expressed as a percentage of the total number of vessels
counted.
2.5. Statistics
Data aremean (± SEM) from three experiments, eachwith at least
three replicates. P-values calculated by Student’s non-paired t-test. *
P < 0.05, ** P < 0.01, *** P < 0.001.3. Results
3.1. Location of thymic CD248
We have previously reported that thymic CD248 expression is
downregulated post-natally, with little/no expression in the adult
thymus [17]. During ontogeny CD248 expression is observed in the
perithymicmesenchyme that forms the thymic capsule, co-expressed
PDGFRα conﬁrming their mesenchymal origin (Fig. 1A). In addition,
CD248 is detected on perivascular cells which invaginate from the
capsule to surround the CD31+ vasculature (Fig. 1B).
3.2. CD248 is required for optimal post-natal thymus growth
During post-natal development the thymus ﬁrst undergoes rapid
logarithmic expansion in size and T-cell output. Growth reaches
homeostasis in adulthood, followed by age-related involution. CD248
expression decreases post-natally in the thymus but is re-expressed
in lymphoid tissue during infection [16,17]. In addition, CD248 plays
a role in regulating tumour expansion and metastasis [18], therefore
we explored the role of CD248 during thymic development inWT and
CD248−/− mice.
WT and CD248−/− thymuses from young (1–2 weeks old), wean-
ing (3–4 weeks old) and adult (9–10 weeks old) mice were weighed
and their cellularity enumerated. All data shown are expressed nor-
malised to body weight, to compensate for any starting differences
in animal size. Thymuses from CD248−/− mice were signiﬁcantly
smaller and contained signiﬁcantly fewer thymocytes by the time
Fig. 2. CD248 is required for efﬁcient post-natal thymic development. Thymic weight
and cellularity are reduced in young (1–2 weeks old), weaning (3–4 weeks old) and
adult (9–10 weeks old) CD248−/− mice (A). Flow cytometry revealed a decrease in
mature (B) and DN thymocyte populations (C) in CD248−/− mice.
of weaning compared to WT thymuses (Fig. 2A). This difference con-
tinued into adulthood, although reduced.
Flow cytometric analysis revealed these differenceswere predom-
inantly due to a signiﬁcant decrease in the number of double positive
(DP) thymocytes, with signiﬁcant decreases in total CD4+ single posi-
tive (SP), total CD8+ SP and double negative (DN) thymocytes also ob-
served (Fig. 2B). Analysis of DN thymocyte subsets (DN1–4) revealed
signiﬁcant differences in all subsets at different times (Fig. 2C). It is
interesting to note, that only DN3 thymocytes showed a consistent
decrease in CD248−/− mice irrespective of age. These cells undergo
rapid proliferation in the sub-capsular zonewhichhas been suggested
Siaˆn Lax et al. / FEBS Open Bio 2 (2012) 187–190 189
Fig. 3. CD248 is required for infection-dependent thymic regeneration. Salmonella infection in CD248−/− mice, as assessed by splenomegaly and the number of bacteria per spleen,
is similar to that of WT (A). Thymic weight and cellularity are reduced during Salmonella infection-dependent regeneration in CD248−/− mice (B). Signiﬁcant loss of thymocyte
populations was observed in CD248−/− mice (C). Re-vascularisation of regenerating thymuses was dysregulated in CD248−/− mice as assessed by ﬂow cytometry of BEC number
(D), and endothelial vessel length in thymuses taken 30 days post-Salmonella infection (E and F). CD248 (green) is upregulated temporally during thymic regeneration (G). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
to regulate thymic growth [22] and requires adhesion of thematuring
thymocyte to extra-cellular matrix generated by MSCs [23].
3.3. CD248 is required for infection-dependent thymic regeneration
Adult thymus involutes during injurious threats such as infection,
regenerating when that threat subsides [7]. Having observed that
CD248was required for optimal thymic growth during post-natal de-
velopment,we reasoned theprocess of thymic regeneration following
infection may also be linked to CD248 expression. Using a model of
systemic Salmonella infection, thymic atrophy is observed, which by
day 21 is accompanied by approximately 95% loss of DP thymocytes
(Ross et al., submitted for publication [24]). This loss is followed by
regeneration, with thymic cellularity and function re-established by
35 days post-infection.
Using this model, we assessed the role of CD248 during infection-
dependent thymic regeneration using CD248−/− mice. The systemic
response to Salmonella infection in CD248−/− mice is similar to that
in WT mice, as assessed by splenic weight and Salmonella accumula-
tion in the spleen (Fig. 3A). In contrast, thymic weight and cellularity
were both signiﬁcantly reduced in CD248−/− mice during infection-
dependent thymic regeneration (Fig. 3B). AssessmentofCD4, CD8 thy-
mocyte subsets during this regenerative-phase revealed a decrease in
numbers of all subpopulations in CD248−/− mice (Fig. 3C).
It has already been reported that tumour growth and metas-
tasis is reduced in CD248−/− mice due to dysregulation of neo-
vascularisation; a signiﬁcant increase in the number of small vessels
was observed with a concomitant decrease in larger, more mature
vessels in CD248−/− mice [18]. Therefore, we analysed the number
of blood endothelial cells (BECs) during infection-dependent thymic
regeneration in WT and CD248−/− mice to quantify vascularisation
of the regenerating thymus. Thymuses were enzymatically digested
and BECs enumerated following ﬂow cytometric analysis (deﬁned
by CD45−EpCAM− gp38−CD31+). Prior to infection, the numbers of
thymic BECs were not signiﬁcantly different when comparing WT to
CD248−/− mice. However, following thymic atrophy and during re-
generation the numbers of BECs were signiﬁcantly and consistently
lower in thymuses lacking CD248 (Fig. 3D). Moreover, when vascular
structureswere stainedwith CD31 and their lengthmeasured 30 days
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post-Salmonella infection, a signiﬁcant increase in small vessels (<25
μm)wasobserved inCD248−/− thymuses (Fig. 3E andF). In addition, a
signiﬁcant decrease in 25–50 μm vessels was observed in CD248−/−
thymuses; a trend that was consistent in larger more mature ves-
sels. Importantly, in WT thymuses perivascular CD248 expression
increases during regeneration (Day 28) but is down-regulated again
once infection is cleared (Day 50) (Fig. 3G).
4. Discussion
Previously we identiﬁed a novel CD248+ cell population required
for efﬁcient popliteal lymph node expansion following NP-CGG im-
munisation [16]. Here we show expression of CD248 on a population
of thymicMSCs is involved in controlling thymic growth during post-
natal development and infection-dependent thymic regeneration.
We have shown that in CD248−/− thymuses, vascularisation dur-
ing infection-dependent regeneration is disrupted and that CD248
expressed on the perivascular cells plays an important role in con-
trolling the size of the thymus and the number of mature thymo-
cytes within the tissue. Interestingly, the reduced size of CD248−/−
thymuses during regeneration correlates to growth of tumours trans-
planted into the abdomen of CD248−/− mice [18]. Therefore, these
data suggest that CD248 regulates both infection and tumorigenic
dependent re-vascularisation. It is interesting that in subcutaneous
tumours no difference in tumour growth was observed between WT
and CD248−/− [18] and during infection-dependent lymph node ex-
pansion the delayed growth of CD248−/− lymph nodes normalised
over time [16]. This may reveal important site-speciﬁc differences in
tissue re-vascularisation.
The ﬁnding that all thymocyte populations remain reduced in
CD248−/− thymuses, even 50 days post-infectionwhenWT thymuses
have re-established function and cellularity, is an intriguing one. This
raises the possibility that CD248 may be important when consider-
ing how thymic structure and function is re-established; not only
in terms of therapies to boost immunity post-infection or treatment
with chemotherapeutic agents (both of which can cause thymic in-
volution), but also on age-related thymic atrophy. Therefore, CD248
may represent a novel molecule that links thymic vascularisation,
function, and size.
Questions still remain, especially when considering possible
mechanisms of how CD248 elicits its effect in thymic MSCs. We and
others have shown that CD248 expression on MSCs confers a prolif-
erative and migratory advantage [16,25,26], possibly via PDGFR sig-
nalling [27]. Having observed an increase in smaller, less mature ves-
sels in CD248−/− thymuses during tissue regeneration, it is possible
that optimal proliferation and migration of CD248+ pericytes sur-
rounding the developing vasculature promotes vessel stabilisation.
Without sufﬁcient perictye support, vascularisation is stunted reduc-
ing the size of epithelial cell niches which permits optimal progenitor
T-cell differentiation. One contributing factor that cannot be ruled
out however, is possible differences in recruitment of Early Thymic
Progenitor to the thymus of CD248−/− mice during development and
regeneration, which may inﬂuence thymic size and cellularity.
Taken together these ﬁndings suggest CD248 plays a role in
re-vascularising thymuses during infection-dependent regeneration,
which may inﬂuence tissue size. Isolating these cells and examin-
ing their ability to alter thymic growth/regeneration and peripheral
immunitywhen transferred into deﬁcient environmentswill be of in-
terest to investigate the contribution of MSCs in immune responses.
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